نتایج جستجو برای: yellow fever vaccination

تعداد نتایج: 186124  

Journal: :Emerging Infectious Diseases 1998
T. P. Monath J. A. Giesberg E. G. Fierros

Yellow fever, the original “viral hemorrhagic fever,” is a mosquito-borne infection characterized by hepatic, renal, and myocardial injury, bleeding, and a high case-fatality rate. The disease occurs in tropical South America and sub-Saharan Africa. Maintained by zoonotic transmission between sylvan mosquitoes and nonhuman primates, the virus cannot be eradicated, and prevention of human infect...

2017
Marjan Wouthuyzen-Bakker Marjolein Knoester Aad P van den Berg Corine H GeurtsvanKessel Marion PG Koopmans Coretta Van Leer-Buter Bob Oude Velthuis Suzan D Pas Wilhelmina LM Ruijs Jonas Schmidt-Chanasit Stephen GS Vreden Tjip S van der Werf Chantal BEM Reusken Wouter FW Bierman

A Dutch traveller returning from Suriname in early March 2017, presented with fever and severe acute liver injury. Yellow fever was diagnosed by (q)RT-PCR and sequencing. During hospital stay, the patient's condition deteriorated and she developed hepatic encephalopathy requiring transfer to the intensive care. Although yellow fever has not been reported in the last four decades in Suriname, va...

2014
Alessandro Pecego Martins Romano Zouraide Guerra Antunes Costa Daniel Garkauskas Ramos Maria Auxiliadora Andrade Valéria de Sá Jayme Marco Antônio Barreto de Almeida Kátia Campomar Vettorello Melissa Mascheretti Brendan Flannery

Due to the risk of severe vaccine-associated adverse events, yellow fever vaccination in Brazil is only recommended in areas considered at risk for disease. From September 2008 through June 2009, two outbreaks of yellow fever in previously unvaccinated populations resulted in 21 confirmed cases with 9 deaths (case-fatality, 43%) in the southern state of Rio Grande do Sul and 28 cases with 11 de...

Journal: :Vaccine 2006
M J Hepburn M G Kortepeter P R Pittman E F Boudreau J A Mangiafico P A Buck S L Norris E L Anderson

A retrospective review was conducted of yellow fever vaccination among laboratory workers receiving annual serologic assessment to determine the initial and long-term response after boosting. Patients were divided into three groups based on pre-vaccination serology: Group 1, 1:10; Group 2, 1:20-1:40 and Group 3, >1:40. The percent with > or = four-fold increase in titers after booster vaccinati...

Journal: :The Journal of Experimental Medicine 2003
W. A. Sawyer S. F. Kitchen Wray Lloyd

1. After preliminary experiments in monkeys, 15 persons were actively immunized by a single injection of a dried mixture of living yellow fever virus, fixed for mice, and human immune serum, with separate injections of enough additional serum to make up the amount required for protection. 2. One person was similarly immunized by injecting immune serum and dried virus separately. 3. By titration...

Journal: :Anais Brasileiros de Dermatologia 2018

Journal: :Journal of Epidemiological Research 2015

2018
Michael M. McNeil Beth F. Hibbs Elaine R. Miller Maria V. Cano

Yellow fever vaccine (YF-VAX, Sanofi Pasteur, Swiftwater, Pennsylvania) is a live, attenuated virus vaccine recommended for persons aged ≥9 months who are traveling to or living in areas with risk for yellow fever virus transmission (1). For persons of all ages for whom vaccination is indicated, a single subcutaneous injection of 0.5 mL of reconstituted vaccine is used. Because no specific trea...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید